LeMaitre Vascular reported Q1 2025 revenue of $59.9M (+12.0% YoY), beat analyst consensus of $57.6M by $2.3M. Diluted EPS came in at $0.48 (+9.1% YoY), missed the $0.50 consensus by $0.02.
Trailing eight quarters through Q1 2025
Common questions about LeMaitre Vascular's Q1 2025 earnings report.
LeMaitre Vascular (LMAT) reported Q1 2025 earnings on May 1, 2025 after market close.
LeMaitre Vascular reported revenue of $59.9M and diluted EPS of $0.48 for Q1 2025.
Revenue beat the consensus estimate of $57.6M by $2.3M. EPS missed the consensus estimate of $0.50 by $0.02.
Compared to the same quarter a year prior, revenue grew 12.0% from $53.5M a year earlier and diluted EPS grew 9.1% from $0.44.
You can read the 10-Q periodic report (0001437749-25-015479) directly on SEC EDGAR. The filing index links above go to sec.gov.